Spacelabs Signs Global Distribution Agreement for Analgesia Pain Monitor
SNOQUALMIE, Wash.--(BUSINESS WIRE)--Spacelabs Healthcare has completed a global partnership agreement with Mdoloris Medical Systems. Mdoloris produces the ANI monitor, which continuously monitors the pain level of patients. Use of the monitor will improve patient care and pain management as drugs can be more precisely administered.
“We are excited to partner with Mdoloris Medical Systems to enhance the patient experience through better pain management”
“We are excited to partner with Mdoloris Medical Systems to enhance the patient experience through better pain management,” noted Nicholas Ong, President Spacelabs Healthcare. “The ANI monitor will become a complimentary product offering in our wide perioperative and critical product portfolio. Spacelabs Healthcare will continue to introduce new technologies to enable clinicians to provide the best care experience to patients and their families.
“It is a pleasure to announce our partnership with Spacelabs, which has such a strong history of innovation in the perioperative and intensive care environments. Spacelabs is a perfect partner to promote the ANI technology, as we share the goal of providing our common customers with the best products and technologies to enhance the quality of care,” said Fabien Pagniez, CEO, Mdoloris Medical Systems.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
About Mdoloris Medical Systems:
Mdoloris (www.mdoloris.com), a medical devices manufacturer, was created in June 2010 out of 23 years of academic research performed in Lille, France. It has an international representation and a scientific, technical and medical acknowledgement.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.